Condition
Traumatic Wounds
Total Trials
6
Recruiting
4
Active
4
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting4
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07255937Not ApplicableCompleted
PMCF Study of Debridement Pad
NCT07617961Recruiting
THERAVEX Tissue Care Spray Plus for the Management of Cutaneous Wounds, Burns, and Chronic Ulcers
NCT07312513Not ApplicableRecruiting
Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With Debrisoft® Pad in the Debridement of Wounds
NCT02280733Recruiting
A Real-World Registry of Chronic Wounds and Ulcers
NCT04920253Not ApplicableRecruiting
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
NCT04826965Not ApplicableTerminated
VAC Bioburden Wound Care Assessment
Showing all 6 trials